Today we proudly welcome Ekolab into the Conscio Group. This strategic partnership enhances our analytical capabilities and solidifies our position as a provider of comprehensive solutions in the Pharmaceutical, Nutrition, and Technology sectors.
Giving back to our local community in Munich is important to everyone at BBA, which is why the entire team spent a Social Day at the Münchner Tafel e.V.
Conscio Group enters strategic partnership with Gen-Plus, further strengthening its service offering for pharmaceutical customers.
BBA CapitalPartners invests in Quinta-Analytica, a leading clinical research organization for the global pharmaceutical industry.
BBA CapitalPartners invests in market leader in laboratory analysis, inspection and certification.